首页   400-620-6333
为了更好地浏览阿拉丁的产品，请在使用“QQ浏览器”或“360浏览器”时切换到极速模式。查看明细
  • 登录
  • 注册
  • 英文站
切换导航
我的购物车
搜索
搜索444
高级搜索
菜单
登录
྾

硫酸长春新碱

微管抑制剂
9篇引用文献
  • ≥98%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
V107236-25mg
 25mg 现货 Stock Image
V107236-100mg
 100mg 现货 Stock Image
V107236-500mg
 500mg 现货 Stock Image
V107236-1g
 1g 现货 Stock Image
V107236-5g
 5g 现货 Stock Image
大包装询价 添加到收藏夹 比较  SDS中文版  DATASHEET
查看相关系列
Apoptosis (1464) Cell Cycle/DNA Damage (2603) Cytoskeleton (498) Microtubule/Tubulin (199)
main product photo

基本描述

别名 硫酸醛基长春碱,硫酸长春醛碱
英文别名 SCHEMBL3710 | VINCRISTINE SULFATE (MART.) | VINCRISTINE SULFATE (USP-RS) | Vincristine sulphate | 22-OXOVINCALEUKOBLASTINE SULFATE (1:1) (SALT) | Leurocristine sulfate (1:1) (salt) | Vincristine Sulfate PFS | LCR SULPHATE | AQTQHPDCURKLKT-JKDPCDLQSA-N | 2
规格或纯度 ≥98%
英文名称 Vincristine sulfate
生化机理 长春新碱是一种植物生物碱，它通过与微管蛋白结合并诱导盘旋聚合体的形成来抑制微管的组装。它通过阻止有丝分裂纺锤体的形成，使细胞周期停滞在 G2/M 期。长春新碱会引发 Raf-1 活化、bcl-2-家族蛋白磷酸化、诱导 p53 表达，并导致多种肿瘤细胞株凋亡。它能抑制白血病细胞株中血管内皮生长因子的生成。它是 Pgp 和 CYP3A4 的底物。MRP1 以 ATP 和 GSH 依赖性方式转运长春新碱。长春新碱具有一定的免疫抑制作用。长春新碱还可能干扰氨基酸、环 AMP 和谷胱甘肽的代谢、钙调素依赖性 Ca2+ 转运、细胞呼吸以及核酸和脂质的生物合成。
储存温度 -20°C储存,充氩
运输条件 超低温冰袋运输
备注 如果有可能，您尽量在使用的当天配置溶液，并在当天使用完它。但是，如果您需要预先配制储备溶液，我们建议您将溶液等份保存在-20°C的密封小瓶中。通常，它们最多可以使用一个月。在使用前和打开样品瓶之前，我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度，用法和处理的建议吗？请访问我们的常见问题（FAQ）页面以获取更多详细信息。
产品介绍

水溶性:＞=1 g/100 mL at 24℃ 广泛地用于癌症研究，多药物抑制，单胺氧化酶（monoamine oxidase）抑制剂。

AI解读

关联靶点（人）

ACHE Tclin Acetylcholinesterase (18204 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GAA Tclin Lysosomal alpha-glucosidase (35701 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
A 172 (535 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
A498 (42825 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
ACHN (49357 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Breast carcinoma cell (217 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CAKI-1 (44928 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CCRF-CEM (65223 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
COLO 205 (50209 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DLD-1 (17511 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DMS-273 (14108 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
DU-145 (51482 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HL-60 (67320 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
HT-29 (80576 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
K562 (73714 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
KM12 (47707 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
M14 (47487 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MCF7 (126967 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
MOLT-4 (49676 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Panel NCI-60 (60 carcinoma cell lines) (1088 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
NFF (353 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
NSCLC (640 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OVCAR-3 (48710 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OVCAR-4 (44535 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OVCAR-5 (45555 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
OVCAR-8 (47708 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
PC-3 (62116 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
RPMI-8226 (44974 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
RXF 393 (41971 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
RXF 631 (11415 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SF-295 (48000 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SK-MEL-2 (46422 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SK-MEL-28 (48833 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SK-MEL-5 (47095 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SK-OV-3 (52876 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SN12C (47755 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SNB-19 (46794 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SNB-78 (14240 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
TK-10 (45540 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
U-251 (51189 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
UACC-257 (46019 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
UACC-62 (47335 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
UO-31 (46270 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
XF498 (12972 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
786-0 (47912 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
A549 (127892 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
NCI/ADR-RES (33767 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
T47D (39041 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Panel breast (Carcinoma cell lines) (123 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CNS cell (47 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

关联靶点（其它种属）

Pseudomonas aeruginosa (123386 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Klebsiella pneumoniae (43867 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Staphylococcus aureus (210822 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Acinetobacter baumannii (41033 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Escherichia coli (133304 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Saccharomyces cerevisiae (19171 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Plasmodium falciparum (966862 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Cryptococcus neoformans (21258 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Candida albicans (78123 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Gallus gallus (1187 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mus musculus (284745 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rattus norvegicus (775804 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rhesus monkey (3147 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
B16 (5829 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
CHO (4503 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
P388 (20296 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
P388/ADR (1216 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
P388/S (109 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
P388/VCR (52 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
4T1 (1737 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
GCN5 Histone acetyltransferase GCN5 (89 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
BCHE Cholinesterase (8742 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Mapt Microtubule-associated protein tau (6 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
TUBB2B Tubulin (2175 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 活性数据)
活性类型 Relation Activity value Units Action Type Journal PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

EC号 218-190-0
分子类型 小分子
IUPAC Name methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid
INCHI InChI=1S/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28-,37+,38-,39-,42+,43-,44-,45+,46+;/m1./s1
InChi Key AQTQHPDCURKLKT-JKDPCDLQSA-N
Canonical SMILES CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
Isomeric SMILES CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
关联CAS 57-22-7(free base)
PubChem CID 249332
UN Number 1544
Packing Group I
分子量 923.04
Beilstein号 3924631

化学和物理性质

溶解性 Soluble in DMSO at 60mg/ml. Soluble in water at 25mg/ml with warming. Very poorly soluble in ethanol
敏感性 易吸潮;对光线敏感
熔点 300 °C
分子量 923.000 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count 5
氢键受体数Hydrogen Bond Acceptor Count 16
可旋转键计数Rotatable Bond Count 10
精确质量Exact Mass 922.367 Da
单同位素质量Monoisotopic Mass 922.367 Da
拓扑极表面积Topological Polar Surface Area 254.000 Ų
重原子数Heavy Atom Count 65
形式电荷Formal Charge 0
复杂度Complexity 1830.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 9
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 2

安全和危险性（GHS）

象形图 GHS06,   GHS08
信号词 Danger
危险声明

H341: 怀疑引起遗传缺陷

H300: 吞咽致命

H361: 怀疑破坏生育力或未出生的孩子
预防措施声明

P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。

P321: 特殊处理（请参阅此标签上的...）。

P405: 密闭存放

P501: 将内容物/容器处理到。。。

P264: 处理后要彻底洗手。

P281: 根据需要使用个人防护设备。

P270: 使用本产品时，请勿进食、饮水或吸烟。

P330: 漱口

P203: 使用前，获取、阅读并遵守所有安全说明。

P301+P316: 如果吞咽：立即寻求紧急医疗救助。

P318: 如果暴露或担心，请就医。
Class 6.1
Merck Index 9986

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到10个结果

批号(Lot Number) 证书类型 日期 货号
B2520076 分析证书 22-02-25 V107236
C2324904 分析证书 22-02-25 V107236
E2204097 分析证书 22-02-25 V107236
E2204105 分析证书 22-02-25 V107236
E2204106 分析证书 22-02-25 V107236
E2312232 分析证书 22-02-25 V107236
L2404099 分析证书 22-02-25 V107236
L2418164 分析证书 22-02-25 V107236
C2226577 分析证书 21-04-09 V107236
C2226666 分析证书 21-04-09 V107236

此产品的引用文献

如何在您的发表作品中引用阿拉丁的产品和网站?
1. Ajmal Muhammad, Wei Jia-Wen, Zhao Yan, Liu Yi-Hong, Wu Ping-Ping, Li Yao-Qun.  (2022)  Derivative Matrix-Isopotential Synchronous Spectrofluorimetry and Hantzsch Reaction: A Direct Route to Simultaneous Determination of Urinary δ-Aminolevulinic Acid and Porphobilinogen.  Frontiers in Chemistry,  10  [PMID:35711951] [10.3389/fchem.2022.920468]
2. Yue-jiao Shi, Hua-xian Zheng, Zhu-ping Hong, Han-bo Wang, Ying Wang, Ming-yan Li, Zhen-Hao Li.  (2021)  Antitumor effects of different Ganoderma lucidum spore powder in cell- and zebrafish-based bioassays.  Journal of Integrative Medicine-JIM,  19  (177).  [PMID:33495135] [10.1016/j.joim.2021.01.004]
3. Muhammad Ajmal, Ali Abbas Falih Shindi, Yi-Hong Liu, Yan Zhao, Ping-Ping Wu, Jia-Wen Wei, Shyamal Kr Ghorai, Shuo Hui Cao, Yao-Qun Li.  (2019)  Derivative matrix-isopotential synchronous spectrofluorimetry: a solution for the direct determination of urinary δ-aminolevulinic acid.  NEW JOURNAL OF CHEMISTRY,  43  (46): (18092-18097).  [10.1039/C9NJ04261J]
4. Shuwei Liu, Lu Wang, Shuyao Li, Xuya Meng, Bin Sun, Xue Zhang, Lening Zhang, Yi Liu, Min Lin, Hao Zhang, Bai Yang.  (2019)  Multidrug resistant tumors-aimed theranostics on the basis of strong electrostatic attraction between resistant cells and nanomaterials.  Biomaterials Science,  7  (12): (4990-5001).  [PMID:31482868] [10.1039/C9BM01017C]
5. Shuwei Liu, Lu Wang, Mengsi Zhang, Kepeng Tao, Bo Wang, Min Lin, Xue Zhang, Yi Liu, Yuchuan Hou, Hao Zhang, Bai Yang.  (2019)  Tumor Microenvironment-Responsive Nanoshuttles with Sodium Citrate Modification for Hierarchical Targeting and Improved Tumor Theranostics.  ACS Applied Materials & Interfaces,  11  (29): (25730–25739).  [PMID:31299144] [10.1021/acsami.9b07957]
6. Tingyu Yu, Jiao Lin, Jin Zhao, Wei Huang, Lingwen Zeng, Zhiyuan Fang, Ning Xu.  (2017)  A simple in vitro tumor chemosensitivity assay based on cell penetrating peptide tagged luciferase.  PLoS One,  12  (11): (e0186184).  [PMID:29125836] [10.1371/journal.pone.0186184]
7. Zhi Liu, Hai-Long Wu, Yong Li, Hui-Wen Gu, Xiao-Li Yin, Li-Xia Xie, Ru-Qin Yu.  (2016)  Rapid and simultaneous determination of five vinca alkaloids in Catharanthus roseus and human serum using trilinear component modeling of liquid chromatography–diode array detection data.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  1026  (114).  [PMID:26321366] [10.1016/j.jchromb.2015.08.008]
8. Li Xue-Mei, Song Jian, Cheng Tao, Fu Pei-Yu.  (2013)  A duplex–triplex nucleic acid nanomachine that probes pH changes inside living cells during apoptosis.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  405  (18): (5993-5999).  [PMID:23695490] [10.1007/s00216-013-7037-4]
9. Jianian Chen, Huijuan He, Shaoshun Li, Qi Shen.  (2011)  An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA–PEG nanoparticle formulations after injection to rats.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  879  (1967).  [PMID:21665557] [10.1016/j.jchromb.2011.05.031]

参考文献

1. Martins CA et al..  (2019)  Pomolic acid exhibits anticancer potential against a docetaxel-resistant PC3 prostate cell line..  Oncol Rep,  42  (328-338).  [PMID:31002376]
2. R M Mohammad,H Diwakaran,A Maki,M A Emara,G R Pettit,B Redman,A al-Katib.  (1995-09-01)  Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma..  Leukemia research,  19  ((9)): (667-673).  [PMID:7564478]
3. K E HAMPEL,H GERHARTZ.  (1964-01-01)  [RESULTS OF CHEMOTHERAPY OF HEMOBLASTOSES WITH VINBLASTINE AND VINCRISTINE SULFATE]..  Krebsforschung und Krebsbekampfung,  30  (97-104).  [PMID:14283724]
4.  (2004-08-06)  Vincristine liposomal--INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system--vincristine, vincacine, vincristine sulfate liposomes for injection, VSLI..  Drugs in R&D,  5  ((2)): (119-123).  [PMID:15293876]
5. Lisa Schulmeister.  (2004-09-21)  Preventing vincristine sulfate medication errors..  Oncology nursing forum,  31  ((5)): (E90-E98).  [PMID:15378106]
6. Jeffrey A Silverman,Steven R Deitcher.  (2012-12-06)  Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine..  Cancer chemotherapy and pharmacology,  71  ((3)): (555-564).  [PMID:23212117]
7. Sang Min Lee,Won Sik Lee,Ho Jin Shin,Je-Jung Lee,Sang Kyun Sohn,Joon Ho Moon,Hyeon Seok Eom,Jong Ho Won,Kyoo-Hyung Lee,Je-Hwan Lee,Dae-Young Kim,Sung-Soo Yoon,Inho Kim,Chul Won Jung,Seok Jin Kim,Hawk Kim,Jae Hoon Lee,Hun-Mo Ryoo,Gyeong-Won Lee,Sung-Hyun Kim,Yeung-Chul Mun,Min Kyoung Kim,Young Don Joo.  (2013-04-06)  Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia..  Annals of hematology,  92  ((8)): (1101-1110).  [PMID:23558905]
8. David Cunningham,Eliza A Hawkes,Andrew Jack,Wendi Qian,Paul Smith,Paul Mouncey,Christopher Pocock,Kirit M Ardeshna,John A Radford,Andrew McMillan,John Davies,Deborah Turner,Anton Kruger,Peter Johnson,Joanna Gambell,David Linch.  (2013-04-26)  Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles..  Lancet (London, England),  381  ((9880)): (1817-1826).  [PMID:23615461]
9. Matthew A Lunning,Alison J Moskowitz,Steven Horwitz.  (2013-05-01)  Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  31  ((16)): (1922-1927).  [PMID:23630204]
10. Arnold C Paulino,Ali Mazloom,Keita Terashima,Jack Su,Adekunle M Adesina,M Faith Okcu,Bin S Teh,Murali Chintagumpala.  (2013-05-02)  Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma..  Cancer,  119  ((14)): (2654-2659).  [PMID:23633429]
11. Kevin Johnson,David M Notrica,David Carpentieri,Dawn Jaroszewski,Michael M Henry.  (2013-05-15)  Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib..  Journal of pediatric hematology/oncology,  35  ((5)): (414-416).  [PMID:23669730]
12. Minoru Mizutani,Yoshiki Nakamori,Haruna Sakaguchi,Yuki Kageyama,Eiko Oya,Kazuko Ino,Kei Suzuki,Takao Sekine.  (2013-05-17)  [Development of syndrome of inappropriate secretion of ADH and reversible posterior leukoencephalopathy during initial rituximab-CHOP therapy in a patient with diffuse large B-cell lymphoma]..  [Rinsho ketsueki] The Japanese journal of clinical hematology,  54  ((3)): (269-272).  [PMID:23676641]
13. Gautam Bhaumik,Koushik Chatterjee.  (2013-06-08)  Spindle cell sarcoma of the maxillary antrum..  Journal of the Indian Medical Association,  110  ((9)): (657-658).  [PMID:23741844]
14. Yuksel Urun,Duygu Kankaya,Lokman Koral,Bulent Yalcin,Ayca Karabork,Koray Ceyhan,Melih Cem Boruban,Güngör Utkan,Ahmet Demirkazik.  (2013-06-12)  Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature..  Tumori,  99  ((2)): (e65-e69).  [PMID:23748832]
15. N V Sachivko,É A Zhavrid,E V Baranov,O A Kolenik.  (2013-07-03)  [Interleukin-2 (Ronkoleykin) in the first-line chemotherapy for B-cell non-Hodgkin lymphoma]..  Voprosy onkologii,  59  ((2)): (52-58).  [PMID:23814850]
16. Huynh Cao,Kenneth Yamamoto,Li-Xi Yang,Robert Weber.  (2013-09-12)  Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma..  Anticancer research,  33  ((9)): (3879-3885).  [PMID:24023323]
17. James O Armitage.  (2013-10-01)  The aggressive peripheral T-cell lymphomas: 2013..  American journal of hematology,  88  ((10)): (910-918).  [PMID:24078271]
18. Yasuhiro Oki,Jason R Westin,Francisco Vega,Hubert Chuang,Nathan Fowler,Sattva Neelapu,Fredrick B Hagemeister,Peter McLaughlin,Larry W Kwak,Jorge E Romaguera,Michelle Fanale,Anas Younes,Maria Alma Rodriguez,Robert Z Orlowski,Michael Wang,Souzanne T Ouzounian,Felipe Samaniego,Luis Fayad.  (2013-10-15)  Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma..  British journal of haematology,  163  ((5)): (611-620).  [PMID:24117234]
19. Qin Huang.  (2013-11-07)  Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia..  Blood,  122  ((13)): (2148-2148).  [PMID:24195124]
20. Akari Hashimoto,Akihito Fujimi,Yuji Kanisawa,Teppei Matsuno,Toshinori Okuda,Shinya Minami,Tadashi Doi,Kazuma Ishikawa,Naoki Uemura,Yuko Jyomen,Utano Tomaru.  (2013-12-18)  [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report]..  Gan to kagaku ryoho. Cancer & chemotherapy,  40  ((13)): (2589-2592).  [PMID:24335377]
21. Hany R Guirguis,Matthew C Cheung,Eugenia Piliotis,David Spaner,Neil L Berinstein,Kevin Imrie,Liying Zhang,Rena Buckstein.  (2014-01-15)  Survival of patients with transformed lymphoma in the rituximab era..  Annals of hematology,  93  ((6)): (1007-1014).  [PMID:24414374]
22. Virginie F Viprey,Walter M Gregory,Maria V Corrias,Andrei Tchirkov,Katrien Swerts,Ales Vicha,Sandro Dallorso,Penelope Brock,Roberto Luksch,Dominique Valteau-Couanet,Vassilios Papadakis,Genevieve Laureys,Andrew D Pearson,Ruth Ladenstein,Susan A Burchill.  (2014-03-05)  Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  32  ((10)): (1074-1083).  [PMID:24590653]
23. Abraham Avigdor,Tsvi Sirotkin,Meirav Kedmi,Elena Ribakovsy,Miriam Berkowicz,Yaron Davidovitz,Abraham Kneller,Drorit Merkel,Yulia Volchek,Tima Davidson,Elinor Goshen,Sara Apter,Avichai Shimoni,Isaac Ben-Bassat,Arnon Nagler.  (2014-03-07)  The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma..  Annals of hematology,  93  ((8)): (1297-1304).  [PMID:24595734]
24. Sacha Satram-Hoang,Carolina Reyes,Khang Q Hoang,Faiyaz Momin,Sandra Skettino.  (2014-03-19)  Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database..  Annals of hematology,  93  ((8)): (1335-1344).  [PMID:24638841]
25. Whitney W Stevens,Peter H S Sporn.  (2014-04-02)  Bilateral diaphragm weakness after chemotherapy for lymphoma..  American journal of respiratory and critical care medicine,  189  ((7)): (e12-e12).  [PMID:24684366]
26. Eva Hoster,Wolfram Klapper,Olivier Hermine,Hanneke C Kluin-Nelemans,Jan Walewski,Achiel van Hoof,Marek Trneny,Christian H Geisler,Francesco Di Raimondo,Michal Szymczyk,Stephan Stilgenbauer,Catherine Thieblemont,Michael Hallek,Roswitha Forstpointner,Christiane Pott,Vincent Ribrag,Jeanette Doorduijn,Wolfgang Hiddemann,Martin H Dreyling,Michael Unterhalt.  (2014-04-02)  Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  32  ((13)): (1338-1346).  [PMID:24687837]
27. Marcus Hentrich,Christian Hoffmann,Franz Mosthaf,Markus Müller,Jan Siehl,Christoph Wyen,Manfred Hensel.  (2014-05-09)  Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG)..  Annals of hematology,  93  ((6)): (913-921).  [PMID:24807241]
28. Adam J Olszewski,Eric S Winer,Jorge J Castillo.  (2014-05-20)  Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma..  Leukemia research,  38  ((8)): (866-873).  [PMID:24837081]
29. Jessica L Heath,Shelly E Burgett,Ana M Gaca,Ronald Jaffe,Daniel S Wechsler.  (2014-06-04)  Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy..  Pediatric blood & cancer,  61  ((10)): (1874-1876).  [PMID:24888336]
30. Armin Rashidi,Elaine M Maherus.  (2014-06-07)  After the treated mole..  Blood,  123  ((18)): (2757-2757).  [PMID:24904937]
31. Mahua Mandal,Michelle J Hindin.  (2014-07-25)  Keeping it in the family: intergenerational transmission of violence in Cebu, Philippines..  Maternal and child health journal,  19  ((3)): (598-605).  [PMID:25055760]
32. Stephany Corrêa,Renata Binato,Bárbara Du Rocher,Gerson Ferreira,Paola Cappelletti,Sheila Soares-Lima,Luis Felipe Pinto,André Mencalha,Eliana Abdelhay.  (2014-08-05)  ABCB1 regulation through LRPPRC is influenced by the methylation status of the GC -100 box in its promoter..  Epigenetics,  9  ((8)): (1172-1183).  [PMID:25089713]
33. Graham W Slack,Christian Steidl,Laurie H Sehn,Randy D Gascoyne.  (2014-08-20)  CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia..  British journal of haematology,  167  ((5)): (608-617).  [PMID:25135752]
34. Grzegorz S Nowakowski,Betsy LaPlant,William R Macon,Craig B Reeder,James M Foran,Garth D Nelson,Carrie A Thompson,Candido E Rivera,David J Inwards,Ivana N Micallef,Patrick B Johnston,Luis F Porrata,Stephen M Ansell,Randy D Gascoyne,Thomas M Habermann,Thomas E Witzig.  (2014-08-20)  Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  33  ((3)): (251-257).  [PMID:25135992]
35. Jörg Thomas Bittenbring,Frank Neumann,Bettina Altmann,Marina Achenbach,Jörg Reichrath,Marita Ziepert,Jürgen Geisel,Evi Regitz,Gerhard Held,Michael Pfreundschuh.  (2014-08-20)  Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  32  ((29)): (3242-3248).  [PMID:25135997]
36. Abo Bakr Abdel Shakor,Mona Atia,Ismail Ahmed Ismail,Ali Alshehri,Hesham El-Refaey,Katarzyna Kwiatkowska,Andrzej Sobota.  (2014-09-23)  Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation..  Biochimica et biophysica acta,  1841  ((12)): (1672-1682).  [PMID:25240837]
37. Jinlong Shi,Baolan Sun,Wei Shi,Hao Zuo,Daming Cui,Lanchun Ni,Jian Chen.  (2014-10-07)  Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation..  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,  36  ((2)): (655-662).  [PMID:25283382]
38. Jacky Wong,Robert Welschinger,John Hewson,Kenneth F Bradstock,Linda J Bendall.  (2014-11-02)  Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia..  Oncotarget,  5  ((21)): (10460-10472).  [PMID:25361005]
39. Daniel O Persky,Thomas P Miller,Joseph M Unger,Catherine M Spier,Soham Puvvada,B Dino Stea,Oliver W Press,Louis S Constine,Kevin P Barton,Jonathan W Friedberg,Michael LeBlanc,Richard I Fisher.  (2014-11-15)  Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313..  Blood,  125  ((2)): (236-241).  [PMID:25395425]
40. Anand Babu,K G Prasanth,Bhaskar Balaji.  (2014-11-29)  Effect of curcumin in mice model of vincristine-induced neuropathy..  Pharmaceutical biology,  53  ((6)): (838-848).  [PMID:25429779]
41. Victoria Cavaliere,Tomás Lombardo,Susana N Costantino,Laura Kornblihtt,Elida M Alvarez,Guillermo A Blanco.  (2014-12-03)  Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine..  European journal of cancer (Oxford, England : 1990),  50  ((18)): (3243-3261).  [PMID:25446377]
42. Offiong F Ikpatt,Drury Reavill,Jason Chatfield,Susan Clubb,Joseph D Rosenblatt,Glenn Fonte,Yao-Shan Fan,Carolyn Cray.  (2015-01-31)  Diagnosis and treatment of diffuse large B-cell lymphoma in an orangutan (Pongo pygmaeus)..  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,  45  ((4)): (935-940).  [PMID:25632687]
43. Howard L McLeod.  (2015-02-25)  Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy..  JAMA,  313  ((8)): (803-804).  [PMID:25710656]
44. Hajime Asada,Hirotaka Tomiyasu,Yuko Goto-Koshino,Yasuhito Fujino,Koichi Ohno,Hajime Tsujimoto.  (2015-02-27)  Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines..  The Journal of veterinary medical science,  77  ((6)): (677-684).  [PMID:25715778]
45. Ling-Yen Chiu,Ming-E Hu,Tsung-Ying Yang,I-Lun Hsin,Jiunn-Liang Ko,Kan-Jen Tsai,Gwo-Tarng Sheu.  (2015-05-07)  Immunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells..  PloS one,  10  ((5)): (e0125774-e0125774).  [PMID:25946033]
46. M Hugle,K Belz,S Fulda.  (2015-05-30)  Identification of synthetic lethality of PLK1 inhibition and microtubule-destabilizing drugs..  Cell death and differentiation,  22  ((12)): (1946-1956).  [PMID:26024389]
47. Eliane May de Lima,Carla Cristine Kanunfre,Lucas Ferrari de Andrade,Daniel Granato,Neiva Deliberali Rosso.  (2015-09-04)  Cytotoxic effect of inositol hexaphosphate and its Ni(II) complex on human acute leukemia Jurkat T cells..  Toxicology in vitro : an international journal published in association with BIBRA,  29  ((8)): (2081-2088).  [PMID:26335902]
48. Scott R Pollack,David J Schenk.  (2015-09-19)  Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry..  Journal of labelled compounds & radiopharmaceuticals,  58  ((11-12)): (433-441).  [PMID:26380956]
49. Toni Grönroos,Artturi Mäkinen,Saara Laukkanen,Juha Mehtonen,Atte Nikkilä,Laura Oksa,Samuli Rounioja,Yanara Marincevic-Zuniga,Jessica Nordlund,Virva Pohjolainen,Timo Paavonen,Merja Heinäniemi,Olli Lohi.  (2020-02-08)  Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia..  Scientific reports,  10  ((1)): (2043-2043).  [PMID:32029838]
50. Andre L Samson,Ying Zhang,Niall D Geoghegan,Xavier J Gavin,Katherine A Davies,Michael J Mlodzianoski,Lachlan W Whitehead,Daniel Frank,Sarah E Garnish,Cheree Fitzgibbon,Anne Hempel,Samuel N Young,Annette V Jacobsen,Wayne Cawthorne,Emma J Petrie,Maree C Faux,Kristy Shield-Artin,Najoua Lalaoui,Joanne M Hildebrand,John Silke,Kelly L Rogers,Guillaume Lessene,Edwin D Hawkins,James M Murphy.  (2020-06-21)  MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis..  Nature communications,  11  ((1)): (3151-3151).  [PMID:32561730]
51. Muhanad Alhujaily,Hafsa Abbas,Mingzhan Xue,Alberto de la Fuente,Naila Rabbani,Paul J Thornalley.  (2021-11-19)  Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome..  Frontiers in oncology,  11  (748698-748698).  [PMID:34790575]
52. Konosuke Nakaji,Yukinori Nakae,Atsuyo Fujita,Mitsutaka Kumamoto,Yasushi Nakamura.  (2013-11-06)  [A case of melena and perforation during chemotherapy for peripheral T-cell lymphoma, not otherwise specified of the small intestine]..  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,  110  ((11)): (1950-1958).  [PMID:24189824]
53. Xin Huang,Bin Meng,Javeed Iqbal,B Belinda Ding,Anamarija M Perry,Wenfeng Cao,Lynette M Smith,Chengfeng Bi,Chunsun Jiang,Timothy C Greiner,Dennis D Weisenburger,Lisa Rimsza,Andreas Rosenwald,German Ott,Jan Delabie,Elias Campo,Rita M Braziel,Randy D Gascoyne,James R Cook,Raymond R Tubbs,Elaine S Jaffe,James O Armitage,Julie M Vose,Louis M Staudt,Timothy W McKeithan,Wing C Chan,B Hilda Ye,Kai Fu.  (2013-11-14)  Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  31  ((36)): (4520-4528).  [PMID:24220563]
54. Robert S Nickel,Frank Keller,John Bergsagel,Todd Cooper,Marla Daves,Himalee Sabnis,Glen Lew.  (2013-12-21)  Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma..  Pediatric blood & cancer,  61  ((5)): (810-814).  [PMID:24357218]
55. Elizabeth A Old,Suchita Nadkarni,John Grist,Clive Gentry,Stuart Bevan,Ki-Wook Kim,Adrian J Mogg,Mauro Perretti,Marzia Malcangio.  (2014-04-20)  Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain..  The Journal of clinical investigation,  124  ((5)): (2023-2036).  [PMID:24743146]
56. Eric Borgstein,Steve Kamiza,Gordan Vujanic,Dalida Pidini,Simon Bailey,Tamiwe Tomoka,Kondwani Banda,Gertjan Kaspers,Elizabeth Molyneux,Trijn Israels.  (2014-09-13)  Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?.  Pediatric blood & cancer,  61  ((12)): (2180-2184).  [PMID:25213396]
57. Weiliang Chen,Donghai Wang,Xinwen Du,Ying He,Songyu Chen,Qianqian Shao,Chao Ma,Bin Huang,Anjing Chen,Peng Zhao,Xun Qu,Xingang Li.  (2015-01-30)  Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes..  Medical oncology (Northwood, London, England),  32  ((3)): (43-43).  [PMID:25631631]
58. Tadeusz Robak,Huiqiang Huang,Jie Jin,Jun Zhu,Ting Liu,Olga Samoilova,Halyna Pylypenko,Gregor Verhoef,Noppadol Siritanaratkul,Evgenii Osmanov,Julia Alexeeva,Juliana Pereira,Johannes Drach,Jiri Mayer,Xiaonan Hong,Rumiko Okamoto,Lixia Pei,Brendan Rooney,Helgi van de Velde,Franco Cavalli.  (2015-03-05)  Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma..  The New England journal of medicine,  372  ((10)): (944-953).  [PMID:25738670]
59. Julie J G Kephart,Rosanne G J Tiller,Lisa E S Crose,Katherine K Slemmons,Po-Han Chen,Ashley R Hinson,Rex C Bentley,Jen-Tsan Ashley Chi,Corinne M Linardic.  (2015-06-14)  Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma..  Clinical cancer research : an official journal of the American Association for Cancer Research,  21  ((21)): (4868-4880).  [PMID:26071485]
60. Ajmal Muhammad, Wei Jia-Wen, Zhao Yan, Liu Yi-Hong, Wu Ping-Ping, Li Yao-Qun.  (2022)  Derivative Matrix-Isopotential Synchronous Spectrofluorimetry and Hantzsch Reaction: A Direct Route to Simultaneous Determination of Urinary δ-Aminolevulinic Acid and Porphobilinogen.  Frontiers in Chemistry,  10  [PMID:35711951] [10.3389/fchem.2022.920468]
61. Yue-jiao Shi, Hua-xian Zheng, Zhu-ping Hong, Han-bo Wang, Ying Wang, Ming-yan Li, Zhen-Hao Li.  (2021)  Antitumor effects of different Ganoderma lucidum spore powder in cell- and zebrafish-based bioassays.  Journal of Integrative Medicine-JIM,  19  (177).  [PMID:33495135] [10.1016/j.joim.2021.01.004]
62. Muhammad Ajmal, Ali Abbas Falih Shindi, Yi-Hong Liu, Yan Zhao, Ping-Ping Wu, Jia-Wen Wei, Shyamal Kr Ghorai, Shuo Hui Cao, Yao-Qun Li.  (2019)  Derivative matrix-isopotential synchronous spectrofluorimetry: a solution for the direct determination of urinary δ-aminolevulinic acid.  NEW JOURNAL OF CHEMISTRY,  43  (46): (18092-18097).  [10.1039/C9NJ04261J]
63. Shuwei Liu, Lu Wang, Shuyao Li, Xuya Meng, Bin Sun, Xue Zhang, Lening Zhang, Yi Liu, Min Lin, Hao Zhang, Bai Yang.  (2019)  Multidrug resistant tumors-aimed theranostics on the basis of strong electrostatic attraction between resistant cells and nanomaterials.  Biomaterials Science,  7  (12): (4990-5001).  [PMID:31482868] [10.1039/C9BM01017C]
64. Shuwei Liu, Lu Wang, Mengsi Zhang, Kepeng Tao, Bo Wang, Min Lin, Xue Zhang, Yi Liu, Yuchuan Hou, Hao Zhang, Bai Yang.  (2019)  Tumor Microenvironment-Responsive Nanoshuttles with Sodium Citrate Modification for Hierarchical Targeting and Improved Tumor Theranostics.  ACS Applied Materials & Interfaces,  11  (29): (25730–25739).  [PMID:31299144] [10.1021/acsami.9b07957]
65. Tingyu Yu, Jiao Lin, Jin Zhao, Wei Huang, Lingwen Zeng, Zhiyuan Fang, Ning Xu.  (2017)  A simple in vitro tumor chemosensitivity assay based on cell penetrating peptide tagged luciferase.  PLoS One,  12  (11): (e0186184).  [PMID:29125836] [10.1371/journal.pone.0186184]
66. Zhi Liu, Hai-Long Wu, Yong Li, Hui-Wen Gu, Xiao-Li Yin, Li-Xia Xie, Ru-Qin Yu.  (2016)  Rapid and simultaneous determination of five vinca alkaloids in Catharanthus roseus and human serum using trilinear component modeling of liquid chromatography–diode array detection data.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  1026  (114).  [PMID:26321366] [10.1016/j.jchromb.2015.08.008]
67. Li Xue-Mei, Song Jian, Cheng Tao, Fu Pei-Yu.  (2013)  A duplex–triplex nucleic acid nanomachine that probes pH changes inside living cells during apoptosis.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  405  (18): (5993-5999).  [PMID:23695490] [10.1007/s00216-013-7037-4]
68. Jianian Chen, Huijuan He, Shaoshun Li, Qi Shen.  (2011)  An HPLC method for the pharmacokinetic study of vincristine sulfate-loaded PLGA–PEG nanoparticle formulations after injection to rats.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,  879  (1967).  [PMID:21665557] [10.1016/j.jchromb.2011.05.031]

溶液计算器

上海阿拉丁生化科技股份有限公司
© 2016 ALADDIN-E.COM . 版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。

上海工商 危险品化学品经营许可证（带存储）营业执照(三证合一)